Pharmacodynamics and Tolerance of Nicotinamide Mononucleotide (NMN, 400mg/Day) in Healthy Adults
Clinical trial NCT04862338 · COMPLETED
Trial details
- NCT number
- NCT04862338
- Sponsor
- Seneque SA
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-26
- Primary completion
- 2021-09-08
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.